Yan Chen

机构：Shandong Normal University · ORCID：0000-0003-3516-9546

发表论文 570 篇 · 总被引 13305 次 · h-index 58

代表论文

• Targeting dormant tumor cells to prevent recurrent breast cancer: a randomized phase 2 trial (2025 · Nature Medicine · 被引 30)
• Targeting spermine metabolism to overcome immunotherapy resistance in pancreatic cancer (2025 · Nature Communications · 被引 13)
• Progress of traditional Chinese medicine in the prevention and treatment of colorectal cancer (2025 · World Journal of Gastrointestinal Oncology · 被引 8)
• Biejia ruangan tablet alleviated liver fibrosis in murine models by hindering the crosstalk between hepatic stellate cells and M2-like macrophages through PDGF-AA/PI3K/AKT pathway (2025 · Journal of Ethnopharmacology · 被引 7)
• UFMylation System: Biological Functions, Molecular Mechanisms, Diseases, and Drug Discovery (2025 · MedComm · 被引 6)
• 177Lu-Dotatate versus high-dose long-acting octreotide for the treatment of patients with advanced, grade 1-2, well-differentiated gastroenteropancreatic neuroendocrine tumours (XT-XTR008-3-01): an open-label, randomised, phase III trial (2025 · Annals of Oncology · 被引 5)